Rare diseases
Investigational molecules
Locations
Oskar-Maria-Graf-Ring 51, Ramersdorf-Perlach, 81737 Munich, Germany
Muenchen Klinik gGmbH in Munich, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Colorectal cancer metastatic, Non-small cell lung cancer metastatic, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.
At Muenchen Klinik gGmbH, the cardiology team is investigating innovative approaches to manage heart attacks, focusing on patients at risk of a recurrent event. The study evaluates the effectiveness of a self‑administered medication to quickly address symptoms of acute myocardial infarction, aiming to improve early treatment outcomes and reduce hospital admissions.
The research involves a multidisciplinary team of 13 investigators and leverages the hospital’s intensive care expertise in Munich to advance cardiovascular care.
The oncology department is conducting cutting‑edge trials in metastatic colorectal cancer, particularly in patients whose tumors exhibit MSI‑High or mismatch repair deficiency. By testing novel immunotherapy combinations, including agents such as MK‑1308A alongside established checkpoint inhibitors, the goal is to enhance tumor response rates and provide new treatment options for advanced disease.
With 13 dedicated investigators, the Munich site is positioned to contribute valuable data to the global effort against colorectal cancer.
Clinical trials currently enrolling participants at this site.
GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
